A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/215 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 47/36 (2006.01)
Patent
CA 2161103
A solid oral sustained release oxybutynin formulation includes a sustained release matrix including a gelling agent, an inert pharmaceutical diluent, and a cationic cross-linking agent.
Une formulation solide orale d'oxybutynine, à libération prolongée, comprend une matrice à libération prolongée renfermant un agent gélifiant, un diluant pharmaceutique inerte et un agent de réticulation cationique.
Bereskin & Parr Llp
Penwest Pharmaceutical Co.
LandOfFree
Controlled release oxybutynin formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release oxybutynin formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release oxybutynin formulations will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1925738